A

AnaptysBio

110 employees

AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immunology
Health Care
Therapeutics
Antibodies
Inflammation
Cancer immunotherapy

Date founded

2005

Funding rounds raised

Total raised

$40M

from 7 investors over 7 rounds

A

AnaptysBio raised $40M on July 15, 2015

Investors: Frazier Healthcare Partners

A

AnaptysBio raised $34M on November 8, 2007

Investors: Numenor Ventures LLC, Frazier Healthcare Partners, Novo Holdings, Alloy Ventures and Avalon Venture

A

AnaptysBio raised $2M on July 31, 2006

Investors: Avalon Venture

FAQ